145 related articles for article (PubMed ID: 8225826)
21. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
22. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
23. [Surgical treatment for 217 patients with bladder transitional carcinoma].
Yu SL; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Wang H; Li YH
Ai Zheng; 2006 Jan; 25(1):73-5. PubMed ID: 16405754
[TBL] [Abstract][Full Text] [Related]
24. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
[TBL] [Abstract][Full Text] [Related]
25. [Multivariable analysis of survival in patients with transitional cell bladder carcinoma].
Li J; Xu X; Ding J
Zhonghua Wai Ke Za Zhi; 1995 Jun; 33(6):353-4. PubMed ID: 8582219
[TBL] [Abstract][Full Text] [Related]
26. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP
J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder.
Yamasaki Y; Smith C; Weisz D; van Huizen I; Xuan J; Moussa M; Stitt L; Hideki S; Cherian MG; Izawa JI
Urology; 2006 Mar; 67(3):530-5. PubMed ID: 16504266
[TBL] [Abstract][Full Text] [Related]
28. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
29. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
Montie JE
J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
[No Abstract] [Full Text] [Related]
30. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
Furihata M; Inoue K; Ohtsuki Y; Hashimoto H; Terao N; Fujita Y
Cancer Res; 1993 Oct; 53(20):4823-7. PubMed ID: 8402668
[TBL] [Abstract][Full Text] [Related]
31. [Clinical observations on bladder cancer--difference in clinical features with age].
Noguchi S; Kubota Y; Shuin T; Masuda M; Yao M; Miura T; Moriyama M; Sakuramoto T; Ishibashi Y; Misaki H
Hinyokika Kiyo; 1993 Dec; 39(12):1131-8. PubMed ID: 8285161
[TBL] [Abstract][Full Text] [Related]
32. [A clinical study of superficial bladder cancer with grade 3 components].
Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S
World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580
[TBL] [Abstract][Full Text] [Related]
34. [Clinical outcome of bladder preserving therapy for superficial high-grade bladder cancer].
Chiba K; Hirokawa M; Saito K; Urushibara M; Yumura Y; Saito K; Okada Y
Hinyokika Kiyo; 1997 May; 43(5):329-32. PubMed ID: 9208315
[TBL] [Abstract][Full Text] [Related]
35. Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.
Okegawa T; Odagane A; Ide H; Horie S; Nutahara K; Higashihara E
Int J Urol; 2006 May; 13(5):493-7. PubMed ID: 16771714
[TBL] [Abstract][Full Text] [Related]
36. [The study of relationship between nuclear metrix protein 22 urinary level and the grade and stage of bladder transitional cell carcinoma].
Xin DQ; You R; Ding Y; Liu LQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):681-3. PubMed ID: 16784679
[TBL] [Abstract][Full Text] [Related]
37. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
38. [Consideration of therapeutic choice for grade 3 superficial bladder cancer].
Noguchi S; Kubota Y; Takase K; Masuda M; Yao M; Hosaka M; Miura T; Kondoh I; Kawasaki C; Moriyama M
Hinyokika Kiyo; 1996 Sep; 42(9):635-8. PubMed ID: 8918660
[TBL] [Abstract][Full Text] [Related]
39. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
[TBL] [Abstract][Full Text] [Related]
40. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]